Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Today in Medicine.
Icarus Medical Innovations Named to 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
EIN Presswire
·
August 13, 2025
Ranked No. 302 on the 2025 Inc. 5000 list with 1,283% growth, Icarus Medical is recognized for innovation in orthopedic bracing solutions. CHARLOTTESVILLE, VA, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Icarus Medical Innovations, a...
ICRAPAIN 2025: International Pain Medicine Conference in India Focused on MSK Ultrasound and Interventional Techniques
EIN Presswire
·
August 13, 2025
Global pain specialists to gather in Kolkata for hands-on MSK ultrasound training, regenerative medicine, and advanced interventional pain management workshops. KOLKATA, WEST BENGAL, INDIA, August 13, 2025 /EINPresswire.com/ -- The 9th...
Spectrum Pharmaceuticals (SPPI) Lead Plaintiff Process Re-Opened, Investors with Losses Urged to Contact Hagens Berman Before September 24, 2025 Deadline
GlobeNewswire, Inc.
·
August 13, 2025
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- On August 4, 2025, the court overseeing the pending securities class action styled Christiansen v. Spectrum Pharmaceuticals, Inc., et al., No. 1:22-cv-10292 (S.D.N.Y.) re-opened the lead plaintiff...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE). Such investors are advised to contact Danielle Peyton at...
NVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline - SPPI
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces the reopening of the Lead Plaintiff appointment process in a pending securities class action lawsuit on behalf of investors of Spectrum Pharmaceuticals, Inc. (“Spectrum” or the...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Praxis Precision Medicines, Inc. - PRAX
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Praxis Precision Medicines, Inc. (“Praxis” or the “Company”) (NASDAQ: PRAX). Such investors are advised to contact Danielle Peyton at...
U.S. Pharmaceutical CDMO Market Valuation to Surpass USD 68.57 Billion by 2034
GlobeNewswire, Inc.
·
August 13, 2025
Ottawa, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to a study by Towards Healthcare, a sister firm of Precedence Research, the U.S. pharmaceutical CDMO market was valued at USD 36.77 billion in 2024 and is projected to reach approximately USD...
Loveland Medical Assistant School Opens Doors to New Careers in Healthcare
EIN Presswire
·
August 13, 2025
18-week program blends classroom learning and hands-on training to prepare Loveland students for in-demand careers as certified medical assistants. LOVELAND, CO, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Loveland Medical Assistant...
Retriever Medical Secures U.S. Patent for Revolutionary Expandable Catheter Technology
EIN Presswire
·
August 13, 2025
Patented catheter tech with adjustable lumens promises to revolutionize minimally invasive procedures. #MedicalInnovation #CatheterDesign LAS VEGAS, NV, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- Retriever Medical, a pioneer in medical...
Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT - Advancing Breakthrough Therapy for Chronic Lower Back Pain
GlobeNewswire, Inc.
·
August 13, 2025
PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative and immune cellular therapies, today announced that the U.S. Food and Drug...
Smart Medical Devices Market to Grow at 17.1% CAGR Through 2030
GlobeNewswire, Inc.
·
August 13, 2025
Boston, Aug. 13, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Smart Medical Devices: Global Markets” is projected to grow from $87.7 billion in 2025 to $193.3 billion by the end of 2030, at a compound annual growth...
Nasus Pharma Announces Pricing of $10 Million Initial Public Offering
GlobeNewswire, Inc.
·
August 13, 2025
TEL AVIV, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical...
Biologics Market Will Estimated to Reach 1,140.2 Bn by 2035, Driven by Precision Medicine and Chronic Disease Prevalence
EIN Presswire
·
August 13, 2025
The Global Biologics Market Size is Estimated to reach US$ 1,140.2 Bn and Expanding at a CAGR of 8.8% by 2035 | Transparency Market Research Inc. WILMINGTON, DE, UNITED STATES, August 13, 2025 /EINPresswire.com/ -- The global Biologics Market,...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
GlobeNewswire, Inc.
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare...
Zealmax Ortho at Pharmatech & Health, East Africa 2025, August 21-23, 2025
EIN Presswire
·
August 13, 2025
Zealmax Ortho India is excited to join the Tanzania Pharma Exhibition 2025, happening August 21–23, 2025, at Diamond Jubilee Hall, Dar es Salaam, Tanzania. DAR ES SALAAM, DAR ES SALAAM, TANZANIA, August 13, 2025 /EINPresswire.com/ -- Showcasing...
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
GlobeNewswire, Inc.
·
August 13, 2025
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040,776 shares of common stock...
ARS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Accelerating Growth for neffy® (epinephrine nasal spray)
GlobeNewswire, Inc.
·
August 13, 2025
$15.7 million in revenue, including $12.8 million in neffy U.S. net product revenue in second quarter of 2025 Growth for neffy in the U.S. driven by increased payor access with additional near-term growth anticipated from national...
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease
GlobeNewswire, Inc.
·
August 13, 2025
MALVERN, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Committee for Medicinal Products for Human...
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
GlobeNewswire, Inc.
·
August 13, 2025
Denali’s registration statement on Form S-4 declared effective by the Securities and Exchange Commission Extraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the proposed business combination is scheduled to be...